Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “nicotine” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 97
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 97 pipeline programs matching "nicotine" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

97 results for “nicotine” Back to intelligence hub

Search results

Page 2 of 5
  1. Smoking research cigarettes with e-cigarette

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Addiction

    phase 2 small molecule completed

    1 trial
  2. Transdermal Nicotine Patch

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking

    phase 2 small molecule completed

    1 trial
  3. Transdermal Nicotine patch

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Smoking

    phase 2 small molecule completed

    1 trial
  4. Varenicline Adaptive Protocol

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 2 small molecule completed

    1 trial
  5. Very Low Nicotine Content Cigarettes

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence, Cigarettes, Uncomplicated

    phase 2 small molecule completed

    1 trial
  6. Very low nicotine content cigarettes

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Dependence

    phase 2 small molecule completed

    2 trials
  7. Very low nicotine content cigarettes

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 2 other completed

    2 trials
  8. aerobic exercise

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 2 other completed

    1 trial
  9. lorcaserin

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 2 small molecule completed

    1 trial
  10. nicotine transdermal system

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    phase 2 small molecule completed

    1 trial
  11. transdermal nicotine

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking

    phase 2 small molecule completed

    1 trial
  12. zonisamide

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 2 small molecule completed

    1 trial
  13. Cycloserine

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Addiction

    phase 1 small molecule completed

    1 trial
  14. ECIG liquid vehicles

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Exposure

    phase 1 other completed

    1 trial
  15. Isradipine

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 1 small molecule completed

    1 trial
  16. Mindfulness Training for Smokers

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 1 other completed

    1 trial
  17. Nicotine

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 1 small molecule completed

    1 trial
  18. Nicotine

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Addiction

    phase 1 small molecule completed

    1 trial
  19. Nicotine (Pharmaceutical Productions Inc.)

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Pharmacokinetic Study

    phase 1 small molecule completed

    1 trial
  20. Nicotine Patch

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    phase 1 small molecule completed

    1 trial
  21. Nicotine Pouches

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Pouch Self-Administration

    phase 1 small molecule active

    1 trial
  22. Nicotine Replacement Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 1 small molecule completed

    1 trial
  23. Nicotine gum (C)

    Century Therapeutics

    Tobacco Use

    phase 1 small molecule completed

    2 trials
  24. Nicotine nasal spray 0.5 mg

    BRIGHT MINDS BIOSCIENCES INC.

    Adverse Childhood Experiences

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.